Skip to content

Startups

Page 19





From VCs to loan providers and crowdfunding platforms, those who fund startups are feeling the long-tail effects of a struggling economic environment. But at least we're seeing more transparency about it.






It's accepted that startup employees can lose their equity if they fall afoul of bad leaver clauses or break NDAs. But there are other tripwires that threaten equity even for those who leave on good terms.






Sydney healthcare startup Eucalyptus is the latest company to chase a piece of the growing longevity market with a $995-a-month program called Compound.


As the market shows signs of recovery, Australian VC heavyweights signal a potential surge in Series B and beyond for the latter half of 2024, challenging perceptions of a risk-averse funding landscape.









Last week, plastics recycler Samsara Eco raised $100 million and quantum startup Diraq raised $10 million. Today, another Australian deep tech startup got a cash infusion.













Has the successful IPO of a fast-food giant made the ASX more digestible for Australia's tech startups? Investors say yes, while founders are more cautious.







Next page